Motivational Interviewing

Motivational Interviewing for Opioid Use Disorder is a form of patient-centered counseling that can help patients understand and resolve their reasons for change, encouraging the patient to reduce their opioid use and/or change their opioid-related behaviors to reduce opioid-related consequences.

Evidence-based Scale

Motivational Interviewing for Opioid Use Disorder (MI-OUD) is a form of patient-centered counseling that can help patients understand and resolve their reasons for change, encouraging the patient to reduce their opioid use and/or change their opioid-related behaviors to reduce opioid-related consequences. Although originally designed to address risky alcohol consumption, MI has demonstrated effectiveness for a range of substances, including tobacco, stimulants, and marijuana. This guide focuses on the data for MI-OUD among patients with active non-medical misuse of opioids and does not focus on the data for motivational interviewing as a preventive strategy among those prescribed opioids for pain.

MI-OUD includes open and often evocative questions that help patients reflect on their past experiences, how opioid use affects their life, and what changes need to be made to reduce opioid-related consequences. This conversation also affirms the patient’s past efforts and instills confidence in their ability to reduce their opioid use by acknowledging that the patient has expertise and autonomy. Throughout, the counselor analyzes the patient’s language to identify what is being said against change (sustain talk) and in favor of change (change talk). Within this conversation, the counselor strives to strike a balance between actively listening, often summarizing and repeating what is said to ensure a shared understanding, and guiding the conversation without judgment. The counselor does not try to convince the patient of changing, but rather discusses the possible consequences of change. When ready, the counselor and patient explore the “how” of change and develop a tailored plan to promote opioid-related change, which recognizes that ambivalence is normal and can be resolved.